The quantitative structure activity relationship (QSAR) study is the most cited and reliable computational
technique used for decades to obtain information about a substituent’s physicochemical property and biological activity.
There is step-by-step development in the concept of QSAR from 0D to 2D. These models suffer various limitations that
led to the development of 3D-QSAR. There are large numbers of literatures available on the utility of 3D-QSAR for drug
design. Three-dimensional properties of molecules with non-covalent interactions are served as important tool in the selection
of bioactive confirmation of compounds. With this view, 3D-QSAR has been explored with different advancements like
COMFA, COMSA, COMMA, etc. Some reports are also available highlighting the limitations of 3D-QSAR. In a way, to
overcome the limitations of 3D-QSAR, more advanced QSAR approaches like 4D, 5D and 6D-QSAR have been evolved.
Here, in this present review we have focused more on the present and future of more predictive models of QSAR studies.
The review highlights the basics of 3D to 6D-QSAR and mainly emphasizes the advantages of one dimension over the
other. It covers almost all recent reports of all these multidimensional QSAR approaches which are new paradigms in drug